 Elan Eisenmesser
Concepts (371)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Streptococcus pneumoniae | 5 | 2025 | 159 | 2.710 |
Why?
| | Cyclophilin A | 13 | 2017 | 26 | 2.560 |
Why?
| | Oxidoreductases Acting on CH-CH Group Donors | 3 | 2024 | 23 | 2.220 |
Why?
| | Catalytic Domain | 11 | 2025 | 218 | 1.850 |
Why?
| | Basigin | 5 | 2017 | 25 | 1.730 |
Why?
| | Nuclear Magnetic Resonance, Biomolecular | 22 | 2020 | 257 | 1.640 |
Why?
| | Cyclophilins | 7 | 2023 | 41 | 1.610 |
Why?
| | Models, Molecular | 28 | 2025 | 1492 | 1.600 |
Why?
| | Serine Endopeptidases | 3 | 2025 | 118 | 1.410 |
Why?
| | Interleukin-1 | 9 | 2024 | 958 | 1.410 |
Why?
| | Virulence Factors | 3 | 2022 | 156 | 1.380 |
Why?
| | Protein Conformation | 18 | 2025 | 859 | 1.310 |
Why?
| | Bacterial Proteins | 7 | 2025 | 835 | 1.300 |
Why?
| | Thermodynamics | 3 | 2020 | 408 | 0.970 |
Why?
| | Serine Proteases | 1 | 2025 | 20 | 0.950 |
Why?
| | Mutation | 6 | 2025 | 3717 | 0.890 |
Why?
| | Protein Binding | 18 | 2024 | 2121 | 0.850 |
Why?
| | Evolution, Molecular | 2 | 2024 | 466 | 0.840 |
Why?
| | Coenzymes | 2 | 2024 | 18 | 0.830 |
Why?
| | Molecular Dynamics Simulation | 5 | 2017 | 217 | 0.820 |
Why?
| | Metalloproteases | 1 | 2022 | 44 | 0.800 |
Why?
| | Crystallography, X-Ray | 12 | 2025 | 436 | 0.740 |
Why?
| | Immunoglobulin A | 1 | 2022 | 200 | 0.730 |
Why?
| | Spike Glycoprotein, Coronavirus | 1 | 2021 | 108 | 0.670 |
Why?
| | Bacteria | 4 | 2023 | 820 | 0.670 |
Why?
| | Protease Inhibitors | 1 | 2020 | 106 | 0.670 |
Why?
| | Catalysis | 12 | 2024 | 310 | 0.640 |
Why?
| | Magnetic Resonance Spectroscopy | 9 | 2019 | 539 | 0.600 |
Why?
| | Erythrocytes | 5 | 2021 | 672 | 0.580 |
Why?
| | Binding Sites | 10 | 2021 | 1252 | 0.550 |
Why?
| | Protein Structure, Tertiary | 7 | 2015 | 840 | 0.540 |
Why?
| | Geobacillus | 2 | 2015 | 2 | 0.530 |
Why?
| | Valine | 1 | 2017 | 81 | 0.530 |
Why?
| | Immune Tolerance | 1 | 2019 | 355 | 0.530 |
Why?
| | RNA | 1 | 2023 | 883 | 0.520 |
Why?
| | Protein Structure, Secondary | 8 | 2017 | 341 | 0.520 |
Why?
| | Cellular Reprogramming | 1 | 2017 | 95 | 0.510 |
Why?
| | Energy Metabolism | 3 | 2021 | 874 | 0.510 |
Why?
| | Protein Folding | 5 | 2017 | 266 | 0.500 |
Why?
| | Membrane Transport Proteins | 1 | 2017 | 149 | 0.500 |
Why?
| | Hemorrhagic Fever Virus, Crimean-Congo | 1 | 2015 | 1 | 0.480 |
Why?
| | Receptors, Interleukin-8A | 1 | 2014 | 6 | 0.450 |
Why?
| | Interleukin-8 | 2 | 2020 | 262 | 0.440 |
Why?
| | Recombinant Proteins | 8 | 2025 | 1304 | 0.440 |
Why?
| | Peptide Hydrolases | 1 | 2015 | 107 | 0.440 |
Why?
| | Peptides | 4 | 2014 | 925 | 0.430 |
Why?
| | Pneumococcal Infections | 2 | 2025 | 110 | 0.430 |
Why?
| | Immunity, Innate | 2 | 2019 | 804 | 0.420 |
Why?
| | Humans | 54 | 2025 | 129621 | 0.410 |
Why?
| | Matrix Metalloproteinase 9 | 1 | 2013 | 119 | 0.410 |
Why?
| | Extracellular Space | 1 | 2013 | 120 | 0.410 |
Why?
| | Transforming Growth Factor beta1 | 1 | 2013 | 157 | 0.400 |
Why?
| | Allosteric Regulation | 3 | 2024 | 99 | 0.390 |
Why?
| | Protein Domains | 4 | 2025 | 253 | 0.390 |
Why?
| | Temperature | 2 | 2012 | 636 | 0.390 |
Why?
| | Interleukin-6 | 3 | 2021 | 720 | 0.380 |
Why?
| | Blood Preservation | 3 | 2021 | 271 | 0.380 |
Why?
| | Peptidylprolyl Isomerase | 4 | 2017 | 11 | 0.370 |
Why?
| | Oxidative Stress | 4 | 2025 | 1269 | 0.370 |
Why?
| | Structure-Activity Relationship | 4 | 2018 | 548 | 0.340 |
Why?
| | Enzyme Inhibitors | 3 | 2025 | 827 | 0.340 |
Why?
| | Interleukins | 3 | 2023 | 241 | 0.340 |
Why?
| | Interleukin-13 | 2 | 2001 | 147 | 0.340 |
Why?
| | Anion Exchange Protein 1, Erythrocyte | 2 | 2021 | 22 | 0.330 |
Why?
| | Amino Acid Sequence | 10 | 2025 | 2058 | 0.330 |
Why?
| | Pancreatic Neoplasms | 1 | 2017 | 882 | 0.310 |
Why?
| | Biocatalysis | 2 | 2020 | 68 | 0.310 |
Why?
| | Oxidation-Reduction | 4 | 2025 | 1033 | 0.290 |
Why?
| | Animals | 21 | 2025 | 35360 | 0.290 |
Why?
| | Nucleocapsid Proteins | 2 | 2023 | 25 | 0.290 |
Why?
| | Immunologic Factors | 2 | 2021 | 231 | 0.290 |
Why?
| | DNA Viruses | 1 | 2007 | 11 | 0.290 |
Why?
| | Escherichia coli Proteins | 2 | 2017 | 178 | 0.280 |
Why?
| | Mice | 15 | 2025 | 16937 | 0.270 |
Why?
| | Protein Processing, Post-Translational | 2 | 2018 | 455 | 0.270 |
Why?
| | Amino Acid Motifs | 2 | 2017 | 213 | 0.260 |
Why?
| | Substrate Specificity | 3 | 2017 | 368 | 0.260 |
Why?
| | Exercise Tolerance | 2 | 2019 | 273 | 0.260 |
Why?
| | Thrombopoiesis | 1 | 2025 | 8 | 0.240 |
Why?
| | Megakaryocytes | 1 | 2025 | 32 | 0.240 |
Why?
| | Glyceraldehyde-3-Phosphate Dehydrogenase (Phosphorylating) | 1 | 2025 | 15 | 0.240 |
Why?
| | Anti-Inflammatory Agents | 3 | 2021 | 480 | 0.240 |
Why?
| | Cell Line | 5 | 2021 | 2781 | 0.240 |
Why?
| | Trypsin | 1 | 2025 | 74 | 0.240 |
Why?
| | Allosteric Site | 1 | 2024 | 19 | 0.240 |
Why?
| | Peptide Fragments | 2 | 2000 | 692 | 0.230 |
Why?
| | Viral Proteins | 1 | 2007 | 328 | 0.230 |
Why?
| | Ligands | 4 | 2019 | 622 | 0.230 |
Why?
| | Receptors, Interleukin-1 | 3 | 2021 | 218 | 0.230 |
Why?
| | Molecular Sequence Data | 7 | 2014 | 2832 | 0.230 |
Why?
| | Protein Multimerization | 2 | 2019 | 179 | 0.230 |
Why?
| | NIMA-Interacting Peptidylprolyl Isomerase | 2 | 2023 | 20 | 0.230 |
Why?
| | Haemophilus | 1 | 2024 | 6 | 0.220 |
Why?
| | Corynebacterium | 1 | 2024 | 48 | 0.220 |
Why?
| | Corynebacterium Infections | 1 | 2024 | 40 | 0.220 |
Why?
| | Antibodies, Monoclonal | 2 | 2021 | 1367 | 0.220 |
Why?
| | Enzyme Stability | 2 | 2015 | 69 | 0.220 |
Why?
| | Mammals | 2 | 2023 | 271 | 0.220 |
Why?
| | Acinetobacter baumannii | 1 | 2023 | 18 | 0.220 |
Why?
| | Inflammation | 6 | 2021 | 2736 | 0.220 |
Why?
| | Haemophilus Infections | 1 | 2024 | 39 | 0.220 |
Why?
| | Haemophilus influenzae | 1 | 2024 | 63 | 0.210 |
Why?
| | Bacterial Adhesion | 2 | 2024 | 91 | 0.210 |
Why?
| | Nucleocapsid | 1 | 2023 | 18 | 0.210 |
Why?
| | NAD | 1 | 2023 | 75 | 0.210 |
Why?
| | Amino Acids | 2 | 2017 | 485 | 0.200 |
Why?
| | Blood Donors | 2 | 2021 | 96 | 0.200 |
Why?
| | Streptococcus | 1 | 2022 | 27 | 0.200 |
Why?
| | Serine | 1 | 2023 | 138 | 0.200 |
Why?
| | Blood Banks | 2 | 2021 | 40 | 0.200 |
Why?
| | NADP | 2 | 2021 | 46 | 0.190 |
Why?
| | Gram-Negative Bacteria | 1 | 2022 | 70 | 0.190 |
Why?
| | Wnt Signaling Pathway | 1 | 2023 | 170 | 0.190 |
Why?
| | HEK293 Cells | 2 | 2021 | 697 | 0.190 |
Why?
| | Spinal Cord | 2 | 2021 | 356 | 0.180 |
Why?
| | Arginine | 1 | 2023 | 265 | 0.180 |
Why?
| | Kinetics | 5 | 2015 | 1642 | 0.180 |
Why?
| | Receptors, Interleukin | 1 | 2001 | 43 | 0.180 |
Why?
| | Receptors, Interleukin-18 | 1 | 2021 | 17 | 0.180 |
Why?
| | Protein Renaturation | 1 | 2000 | 4 | 0.180 |
Why?
| | Interleukin-3 | 1 | 2000 | 23 | 0.180 |
Why?
| | Cell Movement | 2 | 2017 | 945 | 0.180 |
Why?
| | Immune Evasion | 1 | 2021 | 56 | 0.180 |
Why?
| | Emergency Responders | 1 | 2021 | 35 | 0.180 |
Why?
| | Monosaccharide Transport Proteins | 1 | 2000 | 49 | 0.180 |
Why?
| | Arthritis, Gouty | 1 | 2020 | 14 | 0.180 |
Why?
| | Cytokines | 3 | 2024 | 2017 | 0.180 |
Why?
| | Multiple Sclerosis, Chronic Progressive | 1 | 2021 | 26 | 0.170 |
Why?
| | Staphylococcus aureus | 1 | 2024 | 438 | 0.170 |
Why?
| | Isomerism | 2 | 2015 | 53 | 0.170 |
Why?
| | Nonprescription Drugs | 1 | 2021 | 66 | 0.170 |
Why?
| | Encephalomyelitis, Autoimmune, Experimental | 1 | 2021 | 59 | 0.170 |
Why?
| | Cell- and Tissue-Based Therapy | 1 | 2021 | 75 | 0.170 |
Why?
| | Staphylococcal Infections | 1 | 2024 | 393 | 0.170 |
Why?
| | Gout | 1 | 2020 | 33 | 0.170 |
Why?
| | ATP-Binding Cassette Transporters | 1 | 2000 | 133 | 0.170 |
Why?
| | Arthritis | 1 | 2020 | 90 | 0.160 |
Why?
| | Multiple Sclerosis, Relapsing-Remitting | 1 | 2021 | 73 | 0.160 |
Why?
| | Cryoelectron Microscopy | 1 | 2020 | 178 | 0.160 |
Why?
| | Interleukin-18 | 1 | 2021 | 237 | 0.160 |
Why?
| | Mitogen-Activated Protein Kinase 1 | 1 | 2020 | 184 | 0.160 |
Why?
| | Complement C3d | 2 | 2010 | 65 | 0.160 |
Why?
| | Prescription Drugs | 1 | 2021 | 112 | 0.160 |
Why?
| | Cyclic AMP-Dependent Protein Kinases | 1 | 2000 | 133 | 0.160 |
Why?
| | Monocarboxylic Acid Transporters | 2 | 2017 | 21 | 0.160 |
Why?
| | Spliceosomes | 2 | 2017 | 46 | 0.160 |
Why?
| | Receptors, Complement 3d | 2 | 2010 | 140 | 0.150 |
Why?
| | Asparagine | 1 | 2018 | 30 | 0.150 |
Why?
| | Antibodies, Neutralizing | 1 | 2021 | 265 | 0.150 |
Why?
| | Intestinal Mucosa | 1 | 2023 | 590 | 0.150 |
Why?
| | Static Electricity | 3 | 2014 | 116 | 0.150 |
Why?
| | Flavin-Adenine Dinucleotide | 1 | 2018 | 14 | 0.150 |
Why?
| | Aspartic Acid | 1 | 2018 | 81 | 0.150 |
Why?
| | Glyceraldehyde-3-Phosphate Dehydrogenases | 1 | 1998 | 13 | 0.150 |
Why?
| | Interleukin-17 | 1 | 2018 | 108 | 0.150 |
Why?
| | Ribonucleoprotein, U4-U6 Small Nuclear | 1 | 2017 | 11 | 0.140 |
Why?
| | Psoriasis | 1 | 2018 | 87 | 0.140 |
Why?
| | Glucose | 2 | 2021 | 1003 | 0.140 |
Why?
| | Cell Line, Tumor | 2 | 2017 | 3215 | 0.140 |
Why?
| | Models, Chemical | 3 | 2016 | 265 | 0.140 |
Why?
| | Spinal Cord Injuries | 1 | 2020 | 194 | 0.140 |
Why?
| | Plasma Membrane Calcium-Transporting ATPases | 1 | 2017 | 10 | 0.140 |
Why?
| | Endothelial Cells | 2 | 2019 | 749 | 0.140 |
Why?
| | Protein Conformation, alpha-Helical | 1 | 2017 | 15 | 0.140 |
Why?
| | Tyrosine | 1 | 1998 | 223 | 0.140 |
Why?
| | Nitrogen Isotopes | 3 | 2012 | 58 | 0.140 |
Why?
| | Gene Expression | 2 | 2025 | 1472 | 0.130 |
Why?
| | Point Mutation | 2 | 2009 | 225 | 0.130 |
Why?
| | Protein Structure, Quaternary | 3 | 2011 | 122 | 0.130 |
Why?
| | Proteolysis | 1 | 2017 | 166 | 0.130 |
Why?
| | Molecular Chaperones | 1 | 2017 | 182 | 0.130 |
Why?
| | Proteasome Endopeptidase Complex | 1 | 2017 | 148 | 0.130 |
Why?
| | Protein Interaction Domains and Motifs | 1 | 2017 | 139 | 0.130 |
Why?
| | RNA Splicing | 1 | 2017 | 262 | 0.130 |
Why?
| | Tumor Burden | 1 | 2017 | 286 | 0.120 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2017 | 287 | 0.120 |
Why?
| | Structural Homology, Protein | 1 | 2015 | 25 | 0.120 |
Why?
| | Cell Adhesion | 1 | 2017 | 452 | 0.120 |
Why?
| | Hemorrhagic Fever, Crimean | 1 | 2015 | 1 | 0.120 |
Why?
| | RNA Interference | 1 | 2017 | 448 | 0.120 |
Why?
| | Mice, Nude | 1 | 2017 | 683 | 0.120 |
Why?
| | Ubiquitin | 1 | 2015 | 64 | 0.120 |
Why?
| | Calcium Signaling | 1 | 2017 | 250 | 0.120 |
Why?
| | Disease Models, Animal | 3 | 2020 | 4063 | 0.110 |
Why?
| | Transfection | 1 | 2017 | 911 | 0.110 |
Why?
| | Histidine | 1 | 2014 | 60 | 0.110 |
Why?
| | alpha-Synuclein | 1 | 2014 | 32 | 0.110 |
Why?
| | Cold Temperature | 1 | 2015 | 155 | 0.110 |
Why?
| | Signal Transduction | 3 | 2022 | 4925 | 0.110 |
Why?
| | Proline | 1 | 2014 | 76 | 0.110 |
Why?
| | Mice, Inbred C57BL | 5 | 2025 | 5440 | 0.110 |
Why?
| | Metabolome | 1 | 2017 | 338 | 0.110 |
Why?
| | Antibodies, Monoclonal, Humanized | 1 | 2018 | 759 | 0.110 |
Why?
| | Feedback, Physiological | 1 | 2013 | 77 | 0.100 |
Why?
| | Escherichia coli | 3 | 2025 | 774 | 0.100 |
Why?
| | Protein Tyrosine Phosphatases | 1 | 2014 | 168 | 0.100 |
Why?
| | Hydrogen | 1 | 2012 | 65 | 0.100 |
Why?
| | HIV-1 | 3 | 2010 | 836 | 0.100 |
Why?
| | Aged | 5 | 2022 | 22099 | 0.100 |
Why?
| | Carbon Isotopes | 1 | 2012 | 126 | 0.100 |
Why?
| | Capsid Proteins | 2 | 2010 | 90 | 0.100 |
Why?
| | Lipopolysaccharides | 3 | 2021 | 875 | 0.090 |
Why?
| | Protein Transport | 1 | 2013 | 428 | 0.090 |
Why?
| | In Vitro Techniques | 3 | 2021 | 1085 | 0.090 |
Why?
| | Mice, Inbred BALB C | 2 | 2021 | 1245 | 0.090 |
Why?
| | Mice, Transgenic | 3 | 2021 | 2119 | 0.090 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2014 | 442 | 0.090 |
Why?
| | Metabolomics | 3 | 2021 | 652 | 0.090 |
Why?
| | Capsid | 2 | 2002 | 90 | 0.090 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2017 | 1356 | 0.090 |
Why?
| | Aging | 1 | 2021 | 1776 | 0.090 |
Why?
| | Sequence Homology, Amino Acid | 3 | 2020 | 372 | 0.090 |
Why?
| | Receptors, IgE | 1 | 2010 | 44 | 0.090 |
Why?
| | Up-Regulation | 1 | 2013 | 840 | 0.080 |
Why?
| | Hydrogen Bonding | 3 | 2009 | 149 | 0.080 |
Why?
| | PII Nitrogen Regulatory Proteins | 1 | 2009 | 1 | 0.080 |
Why?
| | DNA Mutational Analysis | 1 | 2011 | 387 | 0.080 |
Why?
| | Time Factors | 2 | 2018 | 6556 | 0.080 |
Why?
| | Multigene Family | 1 | 2010 | 199 | 0.080 |
Why?
| | Syndecan-1 | 1 | 2009 | 27 | 0.080 |
Why?
| | Primary Cell Culture | 2 | 2021 | 160 | 0.080 |
Why?
| | Protein Denaturation | 2 | 2017 | 75 | 0.080 |
Why?
| | Nuclear Proteins | 1 | 2014 | 663 | 0.080 |
Why?
| | Cell Proliferation | 1 | 2017 | 2391 | 0.080 |
Why?
| | Glycolysis | 2 | 2021 | 311 | 0.080 |
Why?
| | Circular Dichroism | 2 | 2017 | 148 | 0.080 |
Why?
| | Interferon-alpha | 1 | 2010 | 194 | 0.080 |
Why?
| | Models, Biological | 4 | 2021 | 1721 | 0.080 |
Why?
| | Brain | 1 | 2021 | 2679 | 0.080 |
Why?
| | Parkinson Disease | 1 | 2014 | 463 | 0.070 |
Why?
| | Protein Engineering | 1 | 2009 | 105 | 0.070 |
Why?
| | Adenylate Kinase | 2 | 2005 | 26 | 0.070 |
Why?
| | Recombinant Fusion Proteins | 2 | 2001 | 643 | 0.070 |
Why?
| | Leukocytes, Mononuclear | 2 | 2021 | 545 | 0.070 |
Why?
| | Protein Isoforms | 1 | 2009 | 391 | 0.070 |
Why?
| | Phosphoric Monoester Hydrolases | 1 | 2007 | 54 | 0.070 |
Why?
| | Virion | 1 | 2007 | 82 | 0.070 |
Why?
| | Muscle, Skeletal | 1 | 2017 | 1614 | 0.070 |
Why?
| | Acute Lung Injury | 1 | 2010 | 279 | 0.070 |
Why?
| | Biomarkers, Tumor | 1 | 2013 | 1181 | 0.070 |
Why?
| | Female | 8 | 2024 | 68770 | 0.060 |
Why?
| | Calorimetry | 2 | 2017 | 66 | 0.060 |
Why?
| | Pliability | 1 | 2005 | 46 | 0.060 |
Why?
| | Thrombopoietin | 1 | 2025 | 5 | 0.060 |
Why?
| | Gene Expression Regulation | 3 | 2021 | 2548 | 0.060 |
Why?
| | Phosphorylation | 2 | 2020 | 1713 | 0.060 |
Why?
| | Hydrogen-Ion Concentration | 2 | 2017 | 544 | 0.060 |
Why?
| | Enzymes | 1 | 2005 | 67 | 0.060 |
Why?
| | Small Molecule Libraries | 1 | 2025 | 86 | 0.060 |
Why?
| | Male | 9 | 2021 | 63674 | 0.060 |
Why?
| | Mice, Knockout | 2 | 2021 | 2871 | 0.050 |
Why?
| | Heme | 1 | 2024 | 77 | 0.050 |
Why?
| | Movement | 1 | 2005 | 269 | 0.050 |
Why?
| | Deuterium | 1 | 2023 | 87 | 0.050 |
Why?
| | Hydrolases | 1 | 2023 | 56 | 0.050 |
Why?
| | Organoids | 1 | 2023 | 104 | 0.050 |
Why?
| | Hematopoietic Stem Cells | 1 | 2025 | 381 | 0.050 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2023 | 375 | 0.050 |
Why?
| | Iron | 1 | 2024 | 288 | 0.050 |
Why?
| | Receptors, Interleukin-13 | 1 | 2001 | 2 | 0.050 |
Why?
| | Interleukin-13 Receptor alpha1 Subunit | 1 | 2001 | 3 | 0.050 |
Why?
| | Blood Platelets | 1 | 2025 | 380 | 0.050 |
Why?
| | Case-Control Studies | 2 | 2020 | 3381 | 0.050 |
Why?
| | Receptors, Interleukin-4 | 1 | 2001 | 15 | 0.050 |
Why?
| | Pentose Phosphate Pathway | 1 | 2021 | 50 | 0.050 |
Why?
| | Mathematics | 1 | 2002 | 102 | 0.050 |
Why?
| | Glutathione Disulfide | 1 | 2021 | 32 | 0.050 |
Why?
| | Ranitidine | 1 | 2021 | 14 | 0.050 |
Why?
| | Macrophage Activation Syndrome | 1 | 2021 | 21 | 0.050 |
Why?
| | Arthritis, Rheumatoid | 1 | 2010 | 1092 | 0.050 |
Why?
| | Phosphotransferases (Alcohol Group Acceptor) | 1 | 2021 | 42 | 0.040 |
Why?
| | Candida albicans | 1 | 2021 | 53 | 0.040 |
Why?
| | Solutions | 1 | 2001 | 151 | 0.040 |
Why?
| | Maltose-Binding Proteins | 1 | 2000 | 10 | 0.040 |
Why?
| | Microspheres | 1 | 2021 | 127 | 0.040 |
Why?
| | Seroepidemiologic Studies | 1 | 2021 | 156 | 0.040 |
Why?
| | Immunoassay | 1 | 2021 | 107 | 0.040 |
Why?
| | Sequence Alignment | 1 | 2001 | 332 | 0.040 |
Why?
| | Avian Sarcoma Viruses | 1 | 2000 | 4 | 0.040 |
Why?
| | Interleukin-4 | 1 | 2001 | 212 | 0.040 |
Why?
| | Endopeptidases | 1 | 2000 | 87 | 0.040 |
Why?
| | Disulfides | 1 | 2000 | 97 | 0.040 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 2000 | 330 | 0.040 |
Why?
| | Healthy Volunteers | 1 | 2021 | 200 | 0.040 |
Why?
| | Peritonitis | 1 | 2020 | 81 | 0.040 |
Why?
| | Hemolysis | 1 | 2021 | 199 | 0.040 |
Why?
| | Motion | 1 | 2020 | 98 | 0.040 |
Why?
| | Homeostasis | 1 | 2023 | 611 | 0.040 |
Why?
| | Interleukin-2 | 1 | 2001 | 436 | 0.040 |
Why?
| | Phosphotyrosine | 1 | 1999 | 36 | 0.040 |
Why?
| | Protein Sorting Signals | 1 | 1999 | 19 | 0.040 |
Why?
| | High-Throughput Screening Assays | 1 | 2021 | 138 | 0.040 |
Why?
| | Stem Cells | 1 | 2023 | 577 | 0.040 |
Why?
| | Erythrocyte Transfusion | 1 | 2021 | 181 | 0.040 |
Why?
| | Glucosephosphate Dehydrogenase | 1 | 2019 | 56 | 0.040 |
Why?
| | Middle Aged | 4 | 2021 | 31150 | 0.040 |
Why?
| | Uric Acid | 1 | 2020 | 161 | 0.040 |
Why?
| | Hemoglobins | 1 | 2021 | 339 | 0.040 |
Why?
| | Enzyme Activation | 1 | 2020 | 811 | 0.040 |
Why?
| | Epithelial Cells | 1 | 2024 | 1065 | 0.040 |
Why?
| | Titrimetry | 2 | 2009 | 10 | 0.040 |
Why?
| | Fructose-Bisphosphate Aldolase | 1 | 1998 | 8 | 0.040 |
Why?
| | Methylation | 1 | 2018 | 230 | 0.040 |
Why?
| | Periplasm | 1 | 2017 | 11 | 0.040 |
Why?
| | Interleukin-1beta | 1 | 2020 | 372 | 0.040 |
Why?
| | Cardiovascular Diseases | 1 | 2010 | 2004 | 0.040 |
Why?
| | Binding, Competitive | 1 | 1998 | 206 | 0.040 |
Why?
| | Ultracentrifugation | 1 | 2017 | 48 | 0.040 |
Why?
| | Protein Unfolding | 1 | 2017 | 31 | 0.040 |
Why?
| | Interferon-gamma | 1 | 2021 | 770 | 0.040 |
Why?
| | Macromolecular Substances | 1 | 1998 | 213 | 0.040 |
Why?
| | Intrinsically Disordered Proteins | 1 | 2017 | 30 | 0.040 |
Why?
| | Adult | 4 | 2021 | 35572 | 0.030 |
Why?
| | Surface Plasmon Resonance | 1 | 2017 | 88 | 0.030 |
Why?
| | Rotarod Performance Test | 1 | 2017 | 16 | 0.030 |
Why?
| | Keratinocytes | 1 | 2018 | 242 | 0.030 |
Why?
| | Mass Spectrometry | 1 | 2000 | 716 | 0.030 |
Why?
| | NF-kappa B | 1 | 2021 | 653 | 0.030 |
Why?
| | Antibodies, Viral | 1 | 2021 | 601 | 0.030 |
Why?
| | Cell Respiration | 1 | 2017 | 98 | 0.030 |
Why?
| | Polymorphism, Genetic | 1 | 2020 | 640 | 0.030 |
Why?
| | Cloning, Molecular | 1 | 2017 | 524 | 0.030 |
Why?
| | Carrier Proteins | 1 | 2000 | 743 | 0.030 |
Why?
| | Recovery of Function | 1 | 2020 | 642 | 0.030 |
Why?
| | Myoblasts | 1 | 2017 | 81 | 0.030 |
Why?
| | Rabbits | 1 | 1998 | 778 | 0.030 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2021 | 1198 | 0.030 |
Why?
| | Oxidative Phosphorylation | 1 | 2017 | 187 | 0.030 |
Why?
| | Machine Learning | 1 | 2021 | 443 | 0.030 |
Why?
| | Glutamic Acid | 1 | 2017 | 237 | 0.030 |
Why?
| | AMP-Activated Protein Kinases | 1 | 2017 | 191 | 0.030 |
Why?
| | Physical Conditioning, Animal | 1 | 2017 | 229 | 0.030 |
Why?
| | Running | 1 | 2017 | 223 | 0.030 |
Why?
| | Buffers | 1 | 2014 | 56 | 0.030 |
Why?
| | Neutrophils | 1 | 2020 | 1205 | 0.030 |
Why?
| | Spectrophotometry, Ultraviolet | 1 | 2014 | 84 | 0.030 |
Why?
| | Electrochemistry | 1 | 2014 | 80 | 0.030 |
Why?
| | Unfolded Protein Response | 1 | 2014 | 53 | 0.030 |
Why?
| | Molecular Docking Simulation | 1 | 2014 | 109 | 0.030 |
Why?
| | Exercise Test | 1 | 2017 | 613 | 0.030 |
Why?
| | Skin | 1 | 2018 | 725 | 0.030 |
Why?
| | Magnesium | 1 | 2014 | 153 | 0.030 |
Why?
| | Amino Acid Substitution | 1 | 2014 | 282 | 0.030 |
Why?
| | Cells, Cultured | 1 | 2020 | 4083 | 0.030 |
Why?
| | Proteomics | 1 | 2018 | 1062 | 0.020 |
Why?
| | Rats | 1 | 2020 | 5499 | 0.020 |
Why?
| | Genetic Predisposition to Disease | 1 | 2020 | 2282 | 0.020 |
Why?
| | Colorado | 1 | 2021 | 4420 | 0.020 |
Why?
| | Lung | 1 | 2024 | 3931 | 0.020 |
Why?
| | Adolescent | 2 | 2021 | 20391 | 0.020 |
Why?
| | Severity of Illness Index | 1 | 2018 | 2742 | 0.020 |
Why?
| | Mutant Proteins | 1 | 2010 | 99 | 0.020 |
Why?
| | Monte Carlo Method | 1 | 2009 | 143 | 0.020 |
Why?
| | Adaptive Immunity | 1 | 2010 | 161 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2020 | 7084 | 0.020 |
Why?
| | Spectrum Analysis, Raman | 1 | 2008 | 41 | 0.020 |
Why?
| | Chloramphenicol O-Acetyltransferase | 1 | 2007 | 37 | 0.020 |
Why?
| | Drug Delivery Systems | 1 | 2010 | 336 | 0.020 |
Why?
| | Molecular Conformation | 1 | 2007 | 144 | 0.020 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2009 | 833 | 0.020 |
Why?
| | Isoenzymes | 1 | 2007 | 302 | 0.020 |
Why?
| | Computer Simulation | 1 | 2009 | 943 | 0.010 |
Why?
| | B-Lymphocytes | 1 | 2010 | 815 | 0.010 |
Why?
| | Water | 1 | 2008 | 448 | 0.010 |
Why?
| | Young Adult | 1 | 2021 | 12426 | 0.010 |
Why?
| | Stereoisomerism | 1 | 2002 | 99 | 0.010 |
Why?
| | Virulence | 1 | 2002 | 255 | 0.010 |
Why?
| | Genetic Vectors | 1 | 2002 | 312 | 0.010 |
Why?
| | Microscopy, Electron | 1 | 2000 | 426 | 0.010 |
Why?
| | Models, Structural | 1 | 1999 | 39 | 0.010 |
Why?
| | Drug Design | 1 | 1999 | 156 | 0.010 |
Why?
|
|
Eisenmesser's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|